ArticleKidney international reports2023

Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study.

Romy N Bouwmeester et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.